investors.medivation.com investors.medivation.com

investors.medivation.com

Medivation | Driven by science. Focused on life.

The investor pages that follow are your resource for financial information about Medivation, Inc. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. August 06, 2015. Medivation Reports Second Quarter 2015 Financial Results. July 16, 2015.

http://investors.medivation.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.MEDIVATION.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 15 reviews
5 star
5
4 star
5
3 star
4
2 star
0
1 star
1

Hey there! Start your review of investors.medivation.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT INVESTORS.MEDIVATION.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Medivation | Driven by science. Focused on life. | investors.medivation.com Reviews
<META>
DESCRIPTION
The investor pages that follow are your resource for financial information about Medivation, Inc. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. August 06, 2015. Medivation Reports Second Quarter 2015 Financial Results. July 16, 2015.
<META>
KEYWORDS
1 about us
2 overview
3 management team
4 board of directors
5 collaborations
6 business development
7 contact/directions
8 compliance
9 product
10 research and development
CONTENT
Page content here
KEYWORDS ON
PAGE
about us,overview,management team,board of directors,collaborations,business development,contact/directions,compliance,product,research and development,enzalutamide,investigator sponsored research,disease education,prostate cancer,newsroom,sec filings
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Medivation | Driven by science. Focused on life. | investors.medivation.com Reviews

https://investors.medivation.com

The investor pages that follow are your resource for financial information about Medivation, Inc. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. August 06, 2015. Medivation Reports Second Quarter 2015 Financial Results. July 16, 2015.

INTERNAL PAGES

investors.medivation.com investors.medivation.com
1

Medivation | Driven by science. Focused on life.

http://investors.medivation.com/transactions.cfm

Jun 22, 2016. Acquisition (Non Open Market). Jun 22, 2016. Acquisition (Non Open Market). Jun 22, 2016. Acquisition (Non Open Market). Jun 22, 2016. Acquisition (Non Open Market). Jun 22, 2016. Acquisition (Non Open Market). Jun 6, 2016. Powell andrew kenneth william. May 6, 2016. 6008 - 60.66. May 5, 2016. Apr 7, 2016. Apr 7, 2016. Acquisition (Non Open Market). Apr 6, 2016. Acquisition (Non Open Market). Mar 14, 2016. Mar 4, 2016. Mar 4, 2016. Mar 4, 2016. Mar 4, 2016. Feb 18, 2016. Feb 18, 2016.

2

Medivation | Driven by science. Focused on life.

http://investors.medivation.com/calculator.cfm

Calculate Current Value and Shares Since: August 30, 1996. Aug 30, 1996. Aug 30, 1996. Jul 27, 1999. Sep 24, 2012. Sep 16, 2015. Aug 26, 2016. 525 Market St., 36th Floor. San Francisco, CA 94105.

3

Medivation Announces Second Quarter 2015 Financial Results Teleconference on August 6, 2015 (NASDAQ:MDVN)

http://investors.medivation.com/releasedetail.cfm?ReleaseID=922535

Laquo; Previous Release. Next Release ». July 16, 2015. Medivation Announces Second Quarter 2015 Financial Results Teleconference on August 6, 2015. SAN FRANCISCO, CA. NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss second quarter 2015 financial results and provide a general business update on. August 6, 2015. 4:30 pm Eastern Time. A press release for the second quarter of 2015 will be released after markets close on. August 6, 2015.

4

Medivation | Driven by science. Focused on life.

http://investors.medivation.com/governance.cfm

Nominating and Corporate Governance Committee Charter. Code of Conduct and Ethics. Description of Medivation's Comprehensive Compliance Program. Medivation's Annual Declaration of Compliance of Compliance for the State of California. Add file to Briefcase. 525 Market St., 36th Floor. San Francisco, CA 94105.

5

Medivation | Driven by science. Focused on life.

http://investors.medivation.com/stocklookup.cfm

Week of August 22, 2016. Aug 22, 2016. Aug 23, 2016. Aug 24, 2016. Aug 25, 2016. Aug 26, 2016. Year End Stock Prices. The historical stock information provided is for informational purposes only and is not intended for trading purposes. The historical stock information is provided by Mergent, a third party service, and Medivation, Inc. does not maintain or provide information directly to this service. Prices display split-adjusted cost basis per share on that date. 525 Market St., 36th Floor.

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

OTHER SITES

investors.mcorp.cx investors.mcorp.cx

Investors - MCorpCX

Skip to main content. SaaS (Software as a Service). Leading the customer experience revolution. Trusted by Fortune 100 and mid-market leaders alike, McorpCX is a leading customer experience management company focused on building shareholder value in the age of smart customers and digital disruption. LEARN ABOUT OUR OPPORTUNITY. At the intersection of big data, customer insight and cloud software. Current and historical share data and transfer agent contact. Recent and historical news and press releases.

investors.mdunetech.com investors.mdunetech.com

MDU Network Technologies

Your slogan goes here. Welcome to MDU Network Technologies. MDU is what we do. If you are here, you are either a property owner or resident at a property served by our company. If a resident, you might be looking for our help desk to assist with immediate system enrollment or access issues. Please call (877) 947-3457. Our team should have you online in mere minutes if not seconds. Happy surfing. We eat, sleep, and breathe bandwith; plain and simple. Fiber optics is the. Medium that can provide for the in...

investors.meadjohnson.com investors.meadjohnson.com

Investors | Mead Johnson Corporate

United States - Healthcare Professionals. Nutrition and Your Child. Shareholder Services and FAQs. Press Releases and Statements. Enter the terms you wish to search for. Data Provided by Thomson Reuters. 160;010 (0.11%). 08/07/15  4:00 pm ET. Minimum 20 minute delay. Mead Johnson Nutrition Reports Second Quarter and First-Half 2015 Earnings Consistent with Previous Announcement. Mead Johnson Updates 2015 Financial Guidance. MJN: Positioned for Superior Value Creation. Vice President - Investor Relations.

investors.medefile.com investors.medefile.com

MedeFile - Take control of your medical records!

We have enhanced your MedeFile experience to serve you with more features. We take pride in empowering you with the help and tools you need to be in control of your health and your medical information at all times. See what s new. Your entire medical history at your fingertips. Medefile makes your life simpler, helping you get the best possible treatment and making your vital information available whenever it is needed. See plans and pricing. People everywhere are trusting Medefile! See plans and pricing.

investors.medicinova.com investors.medicinova.com

Investor Home | MediciNova

160; 0.07. Data as of 08/07/15 4:00 pm ET. Minimum 20 minute delay. There are currently no events scheduled. There are currently no items available. Sign up to receive email alerts whenever Medicinova Inc posts new information to the site. Just enter your email address and click Submit.

investors.medivation.com investors.medivation.com

Medivation | Driven by science. Focused on life.

The investor pages that follow are your resource for financial information about Medivation, Inc. Medivation, Inc. is a biopharmaceutical company focused on the rapid development of medically innovative therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. August 06, 2015. Medivation Reports Second Quarter 2015 Financial Results. July 16, 2015.

investors.medivation.net investors.medivation.net

medivation.net

investors.mekonomen.se investors.mekonomen.se

Mekonomen - Mekonomen

investors.memc.com investors.memc.com

Overview | SunEdison

Financial and SEC Filings. Global Ethics and Compliance. Code of Business Conduct. Gifts and Entertainment Policy. In Supply Chain Act Statement. Financial and SEC Filings. Global Ethics and Compliance. Code of Business Conduct. Gifts and Entertainment Policy. In Supply Chain Act Statement. Q2 2015 SunEdison, Inc and TerraForm Power, Inc. Earnings Conference Call. 160;at 8:00 am ET. Q2 2015 Earnings Conference Call Presentation. August 06, 2015. August 06, 2015. 08/06/15 8:00 am ET. 160; 2.12.

investors.merck.com investors.merck.com

Merck & Co., Inc. - Investors

Skip to main content. Reimbursement Support and Patient Assistance Programs. Employment Privacy and Data Protection. Access to Investigational Medicines. Responsible Public Policy and Advocacy. Vaccines and Prescribing Information. Prescription Products and Prescribing Information. Oncology Products and Prescribing Information. Our People, Our Culture. What We're Working On. Business Development and Licensing. Research and Development News. From Service to Science. How Will You Invent the Future? Merck R...

investors.meritagehomes.com investors.meritagehomes.com

IRWeblink

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.